Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Letters to the Editor

Colorectal cancer screening

Folic acid supplementation alters the equation

Mark R. Goldstein, MD, FACP, Luca Mascitelli, MD and Zakia H. Rauf, MD
Cleveland Clinic Journal of Medicine December 2019, 86 (12) 774; DOI: https://doi.org/10.3949/ccjm.86c.12001
Mark R. Goldstein
Center for Healthy Living Naples, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Mascitelli
Comando Brigata Alpina “Julia” Multinational Land Force, Medical Service Udine, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zakia H. Rauf
NCH Academic Internal Medicine Clinic Naples, FL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

TO THE EDITOR: In their paper on colorectal cancer screening, Mankaney and colleagues noted the increasing rates of colorectal cancer in young adults in the United States.1 Recent epidemiologic data demonstrate an increasing incidence of the disease in people ages 40 through 49 since the mid-1990s.2 Even though screening starting at age 45 is not uniformly accepted,1 there is evidence supporting earlier screening.

During the mid-1990s, the US government mandated that all enriched flour and uncooked cereal grains were to be fortified with folic acid in order to prevent births complicated by neural tube defects.3 Subsequently, there was a 2-fold increase in plasma folate concentrations and, disturbingly, a temporally associated significant increase in the incidence of colorectal cancer.3

Notably, a US trial4 testing the efficacy of folic acid 1 mg taken daily for 6 years to prevent colorectal adenomas in those with a history of colorectal adenomas failed to show a reduction in adenoma risk. Instead, participants randomized to folic acid exhibited a significantly increased risk of an advanced adenoma. Another trial,5 conducted in the Netherlands, where there is no mandatory folic acid fortification, investigated folic acid 400 μg and vitamin B12 500 μg daily over 2 to 3 years for the prevention of osteoporotic fractures. The group randomized to the vitamins had a nearly 2-fold increase in the risk of colorectal cancer.

Folic acid can be a double-edged sword.3,5 Although folic acid intake may protect against carcinogenesis through increased genetic stability, if precancerous or neoplastic cells are present, excess folic acid may promote cancer by increasing DNA synthesis and cell proliferation. Cancer cells have folic acid receptors.

Since screening colonoscopy is typically done in individuals over 50, advanced adenomas from folic acid exposure in people younger than 50 likely go undiagnosed. Therefore, colorectal cancer screening should start at a younger age in countries where folic acid fortification is mandatory.

  • © 2019 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Mankaney G,
    2. Sutton RA,
    3. Burke CA
    . Colorectal cancer screening: choosing the right test. Cleve Clin J Med 2019; 86(6):385–392. doi:10.3949/ccjm.86a.17125
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Meester RGS,
    2. Mannalithara A,
    3. Lansdorp-Vogelaar I,
    4. Ladabaum U
    . Trends in incidence and stage at diagnosis of colorectal cancer in adults aged 40 through 49 years, 1975–2015. JAMA 2019; 321(19):1933–1934. doi:10.1001/jama.2019.3076
    OpenUrlCrossRefPubMed
  3. ↵
    1. Mason JB,
    2. Dickstein A,
    3. Jacques PF, et al
    . A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007;16(7):1325–1329. doi:10.1158/1055-9965.EPI-07-0329
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Cole BF,
    2. Baron JA,
    3. Sandler RS, et al; POlyp Prevention Study Group
    . Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297(21):2351–2359. doi:10.1001/jama.297.21.2351
    OpenUrlCrossRefPubMed
  5. ↵
    1. Oliai Araghi S,
    2. Kiefte-de Jong JC,
    3. van Dijk SC, et al
    . Folic acid and vitamin B12 supplementation and the risk of cancer: long-term follow-up of the B vitamins for the prevention of osteoporotic fractures (B-PROOF) Trial. Cancer Epidemiol Biomarkers Prev 2019;28(2):275–282. doi:10.1158/1055-9965.EPI-17-1198
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 86 (12)
Cleveland Clinic Journal of Medicine
Vol. 86, Issue 12
1 Dec 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Colorectal cancer screening
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Colorectal cancer screening
Mark R. Goldstein, Luca Mascitelli, Zakia H. Rauf
Cleveland Clinic Journal of Medicine Dec 2019, 86 (12) 774; DOI: 10.3949/ccjm.86c.12001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Colorectal cancer screening
Mark R. Goldstein, Luca Mascitelli, Zakia H. Rauf
Cleveland Clinic Journal of Medicine Dec 2019, 86 (12) 774; DOI: 10.3949/ccjm.86c.12001
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • In Reply: In defense of the anion gap
  • In defense of the anion gap
  • Effective but inaccessible antiobesity medications
Show more Letters to the editor

Similar Articles

Subjects

  • Gastroenterology
  • Oncology
  • Preventive Care

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire